Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Prof Edouard Louis, MD Prof Matthieu Resche-Rigon, MD * Prof David Laharie, MD * Prof Jack Satsangi, DPhil * Nik Ding, MBBS PhD Prof Britta Siegmund, MD Prof Geert D'Haens, MD Laurence Picon, MD Peter Bossuyt, MD Prof Lucine Vuitton, MD Peter Irving, MD Stephanie Viennot, MD Christopher A Lamb, MBBS PhD Richard Pollok, MD Filip Baert, MD Maria Nachury, MD Prof Mathurin Fumery, MD Cyrielle Gillett

Journal title: Lancet Gastroenterology & Hepatology

Journal number: 8(3)

Journal publisher: The Lancet Publishing Group

Published year: 2023

Published pages: 215-227

DOI identifier: 10.1016/s2468-1253(22)00385-5

ISSN: 0140-6736